Patents Assigned to FIRSON
  • Patent number: 10155007
    Abstract: The present invention relates to a synthesis method of preventing the formation of impurities and byproducts in the synthesis of tenofovir disoproxil fumarate (Teno-DF) used as a medicine for hepatitis B and HIV treatment due to its function to promote bioactivities. In the synthesis method of the present invention, an ion-exchange resin (Dowex 50W hydrogen form, sulfonic acidic cation exchange resin) is used to enhance the yield and purity of the compound. The present invention also relates to a method of preparing an oral dissolving film dosage form in the manufacture of a medicine using the tenofovir compound with high purity obtained by the synthesis method of the present invention as an effective ingredient.
    Type: Grant
    Filed: May 19, 2015
    Date of Patent: December 18, 2018
    Assignee: FIRSON
    Inventors: Dong-Jin Kim, Chang-Hui Koo, Il-Hee Cho, Sung-Bae Lee, Dong-Hoon Han
  • Publication number: 20170354668
    Abstract: The present invention relates to a synthesis method of preventing the formation of impurities and byproducts in the synthesis of tenofovir disoproxil fumarate (Teno-DF) used as a medicine for hepatitis B and HIV treatment due to its function to promote bioactivities. In the synthesis method of the present invention, an ion-exchange resin (Dowex 50W hydrogen form, sulfonic acidic cation exchange resin) is used to enhance the yield and purity of the compound. The present invention also relates to a method of preparing an oral dissolving film dosage form in the manufacture of a medicine using the tenofovir compound with high purity obtained by the synthesis method of the present invention as an effective ingredient.
    Type: Application
    Filed: May 19, 2015
    Publication date: December 14, 2017
    Applicant: FIRSON
    Inventors: Dong-Jin Kim, Chang-Hui Koo, II-Hee Cho, Sung-Bae Lee, Dong-Hoon Han